Sandra Milligan

CIK 1859810 · Interim CEO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$428.1K

Companies

4

Total Filings

26

Lifetime Open-Market Net

$75.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GOSS Director 90,050 $0.16 $14.6K $75.2K 8 2026-06-05
SYRE Director $80.79 $0 3 2026-05-29
Aspira Women's Health Inc. (AWH) Delisted Interim CEO 13,644 $0.08 $1.1K $0 5 2025-01-29
OGN Head of Research & Development 30,767 $13.44 $413.5K $0 10 2023-05-08

Recent Filings · Page 2 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-16 SYRE Grant (A) $0 EDGAR
2024-05-06 Aspira Women's Health Inc. (AWH) Delisted Grant (A) $0 EDGAR
2023-11-17 GOSS Buy (P) +32,000 $25.2K EDGAR
2023-06-09 GOSS Grant (A) $0 EDGAR
2023-05-08 OGN Mixed +2,816 -$52.6K EDGAR
2023-05-03 OGN Mixed +1,073 -$20.3K EDGAR
2023-04-04 OGN Mixed +3,849 -$48.8K EDGAR
2023-03-02 OGN Mixed +5,630 -$58.9K EDGAR
2022-07-15 GOSS Grant (A) $0 EDGAR
2022-05-05 OGN Mixed +4,495 -$75.4K EDGAR
Showing 1120 of 26
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.